Our Management
Anish Bhatnagar, MD
Chief Executive Officer

Dr. Bhatnagar was appointed as our Chief Executive Officer in February 2014. He joined us in 2006, and has held positions of increasing responsibility since then, most recently as President and Chief Operating Officer.  Dr. Bhatnagar is a physician with over 15 years of experience in the medical device and biopharmaceutical industries. His experience spans development of biologics, drugs, drug-device combinations and diagnostic as well as therapeutic medical devices. His prior experience includes working at Coulter Pharmaceuticals, Inc. from 1998 to 2000 and Titan Pharmaceuticals, Inc. from 2000 to 2006. He is the author of several peer-reviewed publications, abstracts and book chapters. He obtained his medical degree at SMS Medical College in Jaipur, India and completed his Residency and Fellowship training in the U.S. at various institutions, including Georgetown University Hospital and the University of Pennsylvania.

David O'Toole
Chief Financial Officer

Mr. O’Toole was appointed as our Chief Financial Officer in July 2014. He has more than 30 years of experience in the accounting and finance sectors, and for the past 14 years has focused on the medical device, tools, and diagnostics industry. From September 2012 to June 2014 Mr. O’Toole was Senior Vice President and Chief Financial Officer at Codexis, Inc., a public company focused on developing biocatalysts. From May 2010 to August 2012 Mr. O’Toole was Vice President and Chief Financial Officer at Response Genetics, Inc., and served from May 2008 to August 2010 as Executive Vice President and Chief Financial Officer of Abraxis Bioscience, Inc. From 1992 to 2008, Mr. O’Toole worked at Deloitte & Touche LLP, where he served for 12 of those years as a partner. He worked at Arthur Anderson & Co., from 1984 to 1992, as an international tax manager. Mr. O’Toole received his Bachelor of Science, Accounting from the University of Arizona and is a certified public accountant.

Edward Ebbers
Chief Commercial Officer

Mr. Ebbers joined Capnia in April 2015 to lead the global sales and marketing launch of CoSense. He has over 35 years of commercial leadership experience in both device and pharmaceutical products. From 2013 to 2015, Mr. Ebbers was responsible for the marketing of RetCam with Clarity Medical, the worldwide leader in diagnosing retinopathy of at risk newborn babies, and HOLOS IntraOp, a real-time intraoperative aberrometer for guiding cataract surgeons to achieve better refractive outcomes. From 2006 to 2010, Mr. Ebbers led the global launch of Zeltiq “CoolSculpting”, which became the fastest growing medical device company in North America. From 1999 to 2006, he launched the Thermage radiofrequency technology, which also resulted in a successful IPO. His prior pharmaceutical experience includes launching major brands NAPROSYN and ALEVE and working at 3M Pharmaceuticals, Syntex Laboratories, and Penederm. Mr. Ebbers received his Bachelor of Business Administration Degree from the University of Wisconsin-Eau Claire, and earned an MBA from the University of Minnesota.

Anthony "Tony" Wondka
Vice President, Research and Development

Mr. Wondka was appointed as our Vice President of Research in June 2013. Prior to that, he was a consultant for us since May 2011. He has held management and executive positions in the medical device industry for over 20 years, in large and small companies. From April 2006 to March 2011, Mr. Wondka served as VP of R&D and then VP of Technology and Clinical Affairs for Breathe Technologies, where he invented and co-invented ventilation products that address large unmet needs in chronic obstructive pulmonary disease, or COPD, and obstructive sleep apnea. From July 1997 to April 2006, Mr. Wondka was Director of R&D and VP of Manufacturing at Pulmonx, where he co-invented and led the early development of the Chartis™ diagnostic system and procedure that is used to guide endobronchial lung volume reduction for the treatment of COPD, and is currently being sold in the E.U. Prior to Pulmonx, Mr. Wondka worked at Pfizer subsidiary Shiley (acquired by Covidien) and Bear Medical (acquired by Carefusion), where he held lead roles in engineering and quality assurance, supporting commercialization activities for market leading ENT and respiratory products. He holds over 40 issued or pending patents and has a B.S. in Bioengineering from University of California San Diego.

Gina Phelps
Vice President of Sales

Ms. Phelps joined Capnia in June 2014 and has over 25 years of experience in sales of medical devices and point-of-care diagnostics. Prior to joining Capnia, Ms. Phelps served as Director of Sales (West) for Accumetrics, leading the company’s sales efforts for the VerifyNow® line of hospital-based diagnostics. She held this position from 2011 until the acquisition of Accumetrics by ITC Corporation in 2013. Prior to that, Ms. Phelps was the National Sales Director for Metrika, Inc., where she had a leadership role in the launch of Metrika’s point-of-care diagnostic devices for diabetes management. Metrika was acquired by Bayer Healthcare LLC in 2006. Ms. Phelps continued her sales leadership role for the Metrika products post-acquisition, serving in various positions of increasing responsibility with Bayer Healthcare from 2006 through 2011. She started her career in medical device and diagnostics sales with Roche Diagnostics. Ms. Phelps was a licensed practical nurse and received her B.S. from Utah College of Applied Technology.

Kristen Yen
Vice President, Clinical and Regulatory Affairs

Ms. Yen has over 15 years of clinical research experience in the pharmaceutical and medical device industries. She joined Capnia in 2006 and currently serves as the head of Clinical and Regulatory Affairs. Prior to joining Capnia, she managed multiple U.S. and global clinical studies in oncology for six (6) years and held various positions of increasing responsibility at Titan Pharmaceuticals. She began her career in the industry as a clinical employee at PRA International. She has served as a team member or managed clinical studies in neonatology, neurology, pulmonary/allergy, cardiovascular disease, endocrine/metabolic disease and oncology. She earned a B.S. in Mathematics from University of California Davis and a M.S. in Cell, Molecular and Neurosciences from University of Hawaii Manoa.

 
Terms Of Use  |  Privacy Statement  |  Customer Support  |  Login